4 questions lodged at 2026 Rocket DNA (RKT) virtual AGM

Q1. Why weren't your 1,321 retail retail shareholders offered a Share Purchase Plan on the same terms as the $4m big end of town institutional placement to "sophisticated" investors last November? AT last year's AGM, you suggested this would be likely to happen, then it didn't. Will you offer retail shareholder an SPP before next year's AGM. If now, why not? You owe us.

Q2. Could the chair please comment on why we continue to raise capital through selective placements, rather than doing pro-rata raisings which treat all shareholders equally and don't require any specific shareholder approvals. Please focus on pro-rata raisings in future and don't ask for this extra 10% placement capacity at next year's AGM. Have there been any material proxy protest votes on this resolution?

Q3. As the only director up for election today, could Paul Williamson please outline his capital raising record as a public company director. How many share purchase plans has he been involved in and how many placements without an SPP has he done over the years? What is his overall approach to fair treatment of retail shareholders in capital raisings and why didn't this board offer an SPP after last year's $4m placement?

Q4. Will a copy of the AGM webcast be published on your website for the benefit of the 1200+ shareholders who were unable to tune in live today? I'm travelling to have a Cortisone injection in my back as you read this but would like to know what answers were provided to these questions?

Copyright © 2026 The Mayne Report. All rights reserved

• share
  Share
  • 
    Facebook
  • 
    Twitter
  • email
    Email
  • print
    Print
  • link
    Copy Link
  • cancel
    Cancel